 | • レポートコード：B-GIR09F3127 • 出版社/出版日：GlobalInfoResearch / 2019年9月27日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール • 産業分類：Pharma & Healthcare |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは、人工多能性幹細胞（iPSC）の世界市場について調べ、まとめました。種類別セグメントは、ヒトiPSC、マウスiPSC等、用途別セグメントは、学術研究、医薬品の開発と発見、毒性スクリーニング、再生医学等に区分しました。人工多能性幹細胞（iPSC）の世界市場概観、企業動向、企業別人工多能性幹細胞（iPSC）シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・人工多能性幹細胞（iPSC）の市場概観 ・人工多能性幹細胞（iPSC）の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・人工多能性幹細胞（iPSC）の企業別販売動向、市場シェア、市場集中度、競争動向 ・人工多能性幹細胞（iPSC）の世界市場規模 ・人工多能性幹細胞（iPSC）の北米市場分析（アメリカ、カナダ、メキシコ等） ・人工多能性幹細胞（iPSC）のアメリカ市場規模推移 ・人工多能性幹細胞（iPSC）のカナダ市場規模推移 ・人工多能性幹細胞（iPSC）のメキシコ市場規模推移 ・人工多能性幹細胞（iPSC）のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・人工多能性幹細胞（iPSC）のドイツ市場規模推移 ・人工多能性幹細胞（iPSC）のイギリス市場規模推移 ・人工多能性幹細胞（iPSC）のロシア市場規模推移 ・人工多能性幹細胞（iPSC）のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・人工多能性幹細胞（iPSC）の日本市場規模推移 ・人工多能性幹細胞（iPSC）の中国市場規模推移 ・人工多能性幹細胞（iPSC）の韓国市場規模推移 ・人工多能性幹細胞（iPSC）のインド市場規模推移 ・人工多能性幹細胞（iPSC）の東南アジア市場規模推移 ・人工多能性幹細胞（iPSC）の南米市場分析（ブラジル、アルゼンチン等） ・人工多能性幹細胞（iPSC）の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・人工多能性幹細胞（iPSC）の種類別分析/販売量、売上、市場シェア（ヒトiPSC、マウスiPSC） ・人工多能性幹細胞（iPSC）の用途別分析/市場規模（学術研究、医薬品の開発と発見、毒性スクリーニング、再生医学） ・人工多能性幹細胞（iPSC）の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・人工多能性幹細胞（iPSC）の販売チャネル・代理店・貿易業者・ディーラー分析 |
Description
Scope of the Report:
The global Induced Pluripotent Stem Cells (iPSCs) market is valued at 74 million USD in 2018 and is expected to reach 114.9 million USD by the end of 2024, growing at a CAGR of 11.7% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Induced Pluripotent Stem Cells (iPSCs).
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Induced Pluripotent Stem Cells (iPSCs) market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Induced Pluripotent Stem Cells (iPSCs) market by product type and applications/end industries.
Market Segment by Companies, this report covers
Fujifilm Holding Corporation (CDI)
ReproCELL
Astellas Pharma Inc
Ncardia
Cell Inspire Biotechnology
Sumitomo Dainippon Pharma
Pluricell Biotech
Fate Therapeutics, Inc
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Human iPSCs
Mouse iPSCs
Human iPSCs had a market share of 89% in 2018, followed by Mouse iPSCs.
Market Segment by Applications, can be divided into
Academic Research
Drug Development and Discovery
Toxicity Screening
Regenerative Medicine
Academic Research is the largest segment of Induced Pluripotent Stem Cells (iPSCs) application,with a share of 32% in 2018.
レポート目次Table of Contents
1 Induced Pluripotent Stem Cells (iPSCs) Market Overview
1.1 Product Overview and Scope of Induced Pluripotent Stem Cells (iPSCs)
1.2 Classification of Induced Pluripotent Stem Cells (iPSCs) by Types
1.2.1 Global Induced Pluripotent Stem Cells (iPSCs) Revenue Comparison by Types (2019-2024)
1.2.2 Global Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Types in 2018
1.2.3 Human iPSCs
1.2.4 Mouse iPSCs
1.3 Global Induced Pluripotent Stem Cells (iPSCs) Market by Application
1.3.1 Global Induced Pluripotent Stem Cells (iPSCs) Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Academic Research
1.3.3 Drug Development and Discovery
1.3.4 Toxicity Screening
1.3.5 Regenerative Medicine
1.4 Global Induced Pluripotent Stem Cells (iPSCs) Market by Regions
1.4.1 Global Induced Pluripotent Stem Cells (iPSCs) Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Induced Pluripotent Stem Cells (iPSCs) Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Induced Pluripotent Stem Cells (iPSCs) Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Induced Pluripotent Stem Cells (iPSCs) Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Induced Pluripotent Stem Cells (iPSCs) Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Induced Pluripotent Stem Cells (iPSCs) Status and Prospect (2014-2024)
1.5 Global Market Size of Induced Pluripotent Stem Cells (iPSCs) (2014-2024)
2 Company Profiles
2.1 Fujifilm Holding Corporation (CDI)
2.1.1 Business Overview
2.1.2 Induced Pluripotent Stem Cells (iPSCs) Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Fujifilm Holding Corporation (CDI) Induced Pluripotent Stem Cells (iPSCs) Revenue, Gross Margin and Market Share (2017-2018)
2.2 ReproCELL
2.2.1 Business Overview
2.2.2 Induced Pluripotent Stem Cells (iPSCs) Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 ReproCELL Induced Pluripotent Stem Cells (iPSCs) Revenue, Gross Margin and Market Share (2017-2018)
2.3 Astellas Pharma Inc
2.3.1 Business Overview
2.3.2 Induced Pluripotent Stem Cells (iPSCs) Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Astellas Pharma Inc Induced Pluripotent Stem Cells (iPSCs) Revenue, Gross Margin and Market Share (2017-2018)
2.4 Ncardia
2.4.1 Business Overview
2.4.2 Induced Pluripotent Stem Cells (iPSCs) Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Ncardia Induced Pluripotent Stem Cells (iPSCs) Revenue, Gross Margin and Market Share (2017-2018)
2.5 Cell Inspire Biotechnology
2.5.1 Business Overview
2.5.2 Induced Pluripotent Stem Cells (iPSCs) Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Cell Inspire Biotechnology Induced Pluripotent Stem Cells (iPSCs) Revenue, Gross Margin and Market Share (2017-2018)
2.6 Sumitomo Dainippon Pharma
2.6.1 Business Overview
2.6.2 Induced Pluripotent Stem Cells (iPSCs) Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Sumitomo Dainippon Pharma Induced Pluripotent Stem Cells (iPSCs) Revenue, Gross Margin and Market Share (2017-2018)
2.7 Pluricell Biotech
2.7.1 Business Overview
2.7.2 Induced Pluripotent Stem Cells (iPSCs) Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Pluricell Biotech Induced Pluripotent Stem Cells (iPSCs) Revenue, Gross Margin and Market Share (2017-2018)
2.8 Fate Therapeutics, Inc
2.8.1 Business Overview
2.8.2 Induced Pluripotent Stem Cells (iPSCs) Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Fate Therapeutics, Inc Induced Pluripotent Stem Cells (iPSCs) Revenue, Gross Margin and Market Share (2017-2018)
3 Global Induced Pluripotent Stem Cells (iPSCs) Market Competition, by Players
3.1 Global Induced Pluripotent Stem Cells (iPSCs) Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Induced Pluripotent Stem Cells (iPSCs) Players Market Share
3.2.2 Top 10 Induced Pluripotent Stem Cells (iPSCs) Players Market Share
3.3 Market Competition Trend
4 Global Induced Pluripotent Stem Cells (iPSCs) Market Size by Regions
4.1 Global Induced Pluripotent Stem Cells (iPSCs) Revenue and Market Share by Regions
4.2 North America Induced Pluripotent Stem Cells (iPSCs) Revenue and Growth Rate (2014-2019)
4.3 Europe Induced Pluripotent Stem Cells (iPSCs) Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Revenue and Growth Rate (2014-2019)
4.5 South America Induced Pluripotent Stem Cells (iPSCs) Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Induced Pluripotent Stem Cells (iPSCs) Revenue and Growth Rate (2014-2019)
5 North America Induced Pluripotent Stem Cells (iPSCs) Revenue by Countries
5.1 North America Induced Pluripotent Stem Cells (iPSCs) Revenue by Countries (2014-2019)
5.2 USA Induced Pluripotent Stem Cells (iPSCs) Revenue and Growth Rate (2014-2019)
5.3 Canada Induced Pluripotent Stem Cells (iPSCs) Revenue and Growth Rate (2014-2019)
5.4 Mexico Induced Pluripotent Stem Cells (iPSCs) Revenue and Growth Rate (2014-2019)
6 Europe Induced Pluripotent Stem Cells (iPSCs) Revenue by Countries
6.1 Europe Induced Pluripotent Stem Cells (iPSCs) Revenue by Countries (2014-2019)
6.2 Germany Induced Pluripotent Stem Cells (iPSCs) Revenue and Growth Rate (2014-2019)
6.3 UK Induced Pluripotent Stem Cells (iPSCs) Revenue and Growth Rate (2014-2019)
6.4 France Induced Pluripotent Stem Cells (iPSCs) Revenue and Growth Rate (2014-2019)
6.5 Russia Induced Pluripotent Stem Cells (iPSCs) Revenue and Growth Rate (2014-2019)
6.6 Italy Induced Pluripotent Stem Cells (iPSCs) Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Revenue by Countries
7.1 Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Revenue by Countries (2014-2019)
7.2 China Induced Pluripotent Stem Cells (iPSCs) Revenue and Growth Rate (2014-2019)
7.3 Japan Induced Pluripotent Stem Cells (iPSCs) Revenue and Growth Rate (2014-2019)
7.4 Korea Induced Pluripotent Stem Cells (iPSCs) Revenue and Growth Rate (2014-2019)
7.5 India Induced Pluripotent Stem Cells (iPSCs) Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Induced Pluripotent Stem Cells (iPSCs) Revenue and Growth Rate (2014-2019)
8 South America Induced Pluripotent Stem Cells (iPSCs) Revenue by Countries
8.1 South America Induced Pluripotent Stem Cells (iPSCs) Revenue by Countries (2014-2019)
8.2 Brazil Induced Pluripotent Stem Cells (iPSCs) Revenue and Growth Rate (2014-2019)
8.3 Argentina Induced Pluripotent Stem Cells (iPSCs) Revenue and Growth Rate (2014-2019)
8.4 Colombia Induced Pluripotent Stem Cells (iPSCs) Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Induced Pluripotent Stem Cells (iPSCs) by Countries
9.1 Middle East and Africa Induced Pluripotent Stem Cells (iPSCs) Revenue by Countries (2014-2019)
9.2 Saudi Arabia Induced Pluripotent Stem Cells (iPSCs) Revenue and Growth Rate (2014-2019)
9.3 UAE Induced Pluripotent Stem Cells (iPSCs) Revenue and Growth Rate (2014-2019)
9.4 Egypt Induced Pluripotent Stem Cells (iPSCs) Revenue and Growth Rate (2014-2019)
9.5 Nigeria Induced Pluripotent Stem Cells (iPSCs) Revenue and Growth Rate (2014-2019)
9.6 South Africa Induced Pluripotent Stem Cells (iPSCs) Revenue and Growth Rate (2014-2019)
10 Global Induced Pluripotent Stem Cells (iPSCs) Market Segment by Type
10.1 Global Induced Pluripotent Stem Cells (iPSCs) Revenue and Market Share by Type (2014-2019)
10.2 Global Induced Pluripotent Stem Cells (iPSCs) Market Forecast by Type (2019-2024)
10.3 Human iPSCs Revenue Growth Rate (2014-2024)
10.4 Mouse iPSCs Revenue Growth Rate (2014-2024)
11 Global Induced Pluripotent Stem Cells (iPSCs) Market Segment by Application
11.1 Global Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Application (2014-2019)
11.2 Induced Pluripotent Stem Cells (iPSCs) Market Forecast by Application (2019-2024)
11.3 Academic Research Revenue Growth (2014-2019)
11.4 Drug Development and Discovery Revenue Growth (2014-2019)
11.5 Toxicity Screening Revenue Growth (2014-2019)
11.6 Regenerative Medicine Revenue Growth (2014-2019)
12 Global Induced Pluripotent Stem Cells (iPSCs) Market Size Forecast (2019-2024)
12.1 Global Induced Pluripotent Stem Cells (iPSCs) Market Size Forecast (2019-2024)
12.2 Global Induced Pluripotent Stem Cells (iPSCs) Market Forecast by Regions (2019-2024)
12.3 North America Induced Pluripotent Stem Cells (iPSCs) Revenue Market Forecast (2019-2024)
12.4 Europe Induced Pluripotent Stem Cells (iPSCs) Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Revenue Market Forecast (2019-2024)
12.6 South America Induced Pluripotent Stem Cells (iPSCs) Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Induced Pluripotent Stem Cells (iPSCs) Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
Figure Induced Pluripotent Stem Cells (iPSCs) Picture
Table Product Specifications of Induced Pluripotent Stem Cells (iPSCs)
Table Global Induced Pluripotent Stem Cells (iPSCs) and Revenue (Million USD) Market Split by Product Type
Figure Global Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Types in 2018
Figure Human iPSCs Picture
Figure Mouse iPSCs Picture
Table Global Induced Pluripotent Stem Cells (iPSCs) Revenue (Million USD) by Application (2014-2024)
Figure Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Applications in 2018
Figure Academic Research Picture
Figure Drug Development and Discovery Picture
Figure Toxicity Screening Picture
Figure Regenerative Medicine Picture
Table Global Market Induced Pluripotent Stem Cells (iPSCs) Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Induced Pluripotent Stem Cells (iPSCs) Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Induced Pluripotent Stem Cells (iPSCs) Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Induced Pluripotent Stem Cells (iPSCs) Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Induced Pluripotent Stem Cells (iPSCs) Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Induced Pluripotent Stem Cells (iPSCs) Revenue (Million USD) and Growth Rate (2014-2024)
Table Fujifilm Holding Corporation (CDI) Basic Information, Manufacturing Base and Competitors
Table Fujifilm Holding Corporation (CDI) Induced Pluripotent Stem Cells (iPSCs) Type and Applications
Table Fujifilm Holding Corporation (CDI) Induced Pluripotent Stem Cells (iPSCs) Revenue, Gross Margin and Market Share (2017-2018)
Table ReproCELL Basic Information, Manufacturing Base and Competitors
Table ReproCELL Induced Pluripotent Stem Cells (iPSCs) Type and Applications
Table ReproCELL Induced Pluripotent Stem Cells (iPSCs) Revenue, Gross Margin and Market Share (2017-2018)
Table Astellas Pharma Inc Basic Information, Manufacturing Base and Competitors
Table Astellas Pharma Inc Induced Pluripotent Stem Cells (iPSCs) Type and Applications
Table Astellas Pharma Inc Induced Pluripotent Stem Cells (iPSCs) Revenue, Gross Margin and Market Share (2017-2018)
Table Ncardia Basic Information, Manufacturing Base and Competitors
Table Ncardia Induced Pluripotent Stem Cells (iPSCs) Type and Applications
Table Ncardia Induced Pluripotent Stem Cells (iPSCs) Revenue, Gross Margin and Market Share (2017-2018)
Table Cell Inspire Biotechnology Basic Information, Manufacturing Base and Competitors
Table Cell Inspire Biotechnology Induced Pluripotent Stem Cells (iPSCs) Type and Applications
Table Cell Inspire Biotechnology Induced Pluripotent Stem Cells (iPSCs) Revenue, Gross Margin and Market Share (2017-2018)
Table Sumitomo Dainippon Pharma Basic Information, Manufacturing Base and Competitors
Table Sumitomo Dainippon Pharma Induced Pluripotent Stem Cells (iPSCs) Type and Applications
Table Sumitomo Dainippon Pharma Induced Pluripotent Stem Cells (iPSCs) Revenue, Gross Margin and Market Share (2017-2018)
Table Pluricell Biotech Basic Information, Manufacturing Base and Competitors
Table Pluricell Biotech Induced Pluripotent Stem Cells (iPSCs) Type and Applications
Table Pluricell Biotech Induced Pluripotent Stem Cells (iPSCs) Revenue, Gross Margin and Market Share (2017-2018)
Table Fate Therapeutics, Inc Basic Information, Manufacturing Base and Competitors
Table Fate Therapeutics, Inc Induced Pluripotent Stem Cells (iPSCs) Type and Applications
Table Fate Therapeutics, Inc Induced Pluripotent Stem Cells (iPSCs) Revenue, Gross Margin and Market Share (2017-2018)
Table Global Induced Pluripotent Stem Cells (iPSCs) Revenue (Million USD) by Players (2014-2019)
Table Global Induced Pluripotent Stem Cells (iPSCs) Revenue Share by Players (2014-2019)
Figure Global Induced Pluripotent Stem Cells (iPSCs) Revenue Share by Players in 2017
Figure Global Induced Pluripotent Stem Cells (iPSCs) Revenue Share by Players in 2018
Figure Global Top 5 Players Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share in 2018
Figure Global Top 10 Players Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share in 2018
Figure Global Induced Pluripotent Stem Cells (iPSCs) Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Induced Pluripotent Stem Cells (iPSCs) Revenue (Million USD) by Regions (2014-2019)
Table Global Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Regions (2014-2019)
Figure Global Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Regions (2014-2019)
Figure Global Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Regions in 2018
Figure North America Induced Pluripotent Stem Cells (iPSCs) Revenue and Growth Rate (2014-2019)
Figure Europe Induced Pluripotent Stem Cells (iPSCs) Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Revenue and Growth Rate (2014-2019)
Figure South America Induced Pluripotent Stem Cells (iPSCs) Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Induced Pluripotent Stem Cells (iPSCs) Revenue and Growth Rate (2014-2019)
Table North America Induced Pluripotent Stem Cells (iPSCs) Revenue by Countries (2014-2019)
Table North America Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Countries (2014-2019)
Figure North America Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Countries (2014-2019)
Figure North America Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Countries in 2018
Figure USA Induced Pluripotent Stem Cells (iPSCs) Revenue and Growth Rate (2014-2019)
Figure Canada Induced Pluripotent Stem Cells (iPSCs) Revenue and Growth Rate (2014-2019)
Figure Mexico Induced Pluripotent Stem Cells (iPSCs) Revenue and Growth Rate (2014-2019)
Table Europe Induced Pluripotent Stem Cells (iPSCs) Revenue (Million USD) by Countries (2014-2019)
Figure Europe Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Countries (2014-2019)
Figure Europe Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Countries in 2018
Figure Germany Induced Pluripotent Stem Cells (iPSCs) Revenue and Growth Rate (2014-2019)
Figure UK Induced Pluripotent Stem Cells (iPSCs) Revenue and Growth Rate (2014-2019)
Figure France Induced Pluripotent Stem Cells (iPSCs) Revenue and Growth Rate (2014-2019)
Figure Russia Induced Pluripotent Stem Cells (iPSCs) Revenue and Growth Rate (2014-2019)
Figure Italy Induced Pluripotent Stem Cells (iPSCs) Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Countries in 2018
Figure China Induced Pluripotent Stem Cells (iPSCs) Revenue and Growth Rate (2014-2019)
Figure Japan Induced Pluripotent Stem Cells (iPSCs) Revenue and Growth Rate (2014-2019)
Figure Korea Induced Pluripotent Stem Cells (iPSCs) Revenue and Growth Rate (2014-2019)
Figure India Induced Pluripotent Stem Cells (iPSCs) Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Induced Pluripotent Stem Cells (iPSCs) Revenue and Growth Rate (2014-2019)
Table South America Induced Pluripotent Stem Cells (iPSCs) Revenue by Countries (2014-2019)
Table South America Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Countries (2014-2019)
Figure South America Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Countries (2014-2019)
Figure South America Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Countries in 2018
Figure Brazil Induced Pluripotent Stem Cells (iPSCs) Revenue and Growth Rate (2014-2019)
Figure Argentina Induced Pluripotent Stem Cells (iPSCs) Revenue and Growth Rate (2014-2019)
Figure Colombia Induced Pluripotent Stem Cells (iPSCs) Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Induced Pluripotent Stem Cells (iPSCs) Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Countries in 2018
Figure Saudi Arabia Induced Pluripotent Stem Cells (iPSCs) Revenue and Growth Rate (2014-2019)
Figure UAE Induced Pluripotent Stem Cells (iPSCs) Revenue and Growth Rate (2014-2019)
Figure Egypt Induced Pluripotent Stem Cells (iPSCs) Revenue and Growth Rate (2014-2019)
Figure Nigeria Induced Pluripotent Stem Cells (iPSCs) Revenue and Growth Rate (2014-2019)
Figure South Africa Induced Pluripotent Stem Cells (iPSCs) Revenue and Growth Rate (2014-2019)
Table Global Induced Pluripotent Stem Cells (iPSCs) Revenue (Million USD) by Type (2014-2019)
Table Global Induced Pluripotent Stem Cells (iPSCs) Revenue Share by Type (2014-2019)
Figure Global Induced Pluripotent Stem Cells (iPSCs) Revenue Share by Type (2014-2019)
Figure Global Induced Pluripotent Stem Cells (iPSCs) Revenue Share by Type in 2018
Table Global Induced Pluripotent Stem Cells (iPSCs) Revenue Forecast by Type (2019-2024)
Figure Global Induced Pluripotent Stem Cells (iPSCs) Market Share Forecast by Type (2019-2024)
Figure Global Human iPSCs Revenue Growth Rate (2014-2019)
Figure Global Mouse iPSCs Revenue Growth Rate (2014-2019)
Table Global Induced Pluripotent Stem Cells (iPSCs) Revenue by Application (2014-2019)
Table Global Induced Pluripotent Stem Cells (iPSCs) Revenue Share by Application (2014-2019)
Figure Global Induced Pluripotent Stem Cells (iPSCs) Revenue Share by Application (2014-2019)
Figure Global Induced Pluripotent Stem Cells (iPSCs) Revenue Share by Application in 2018
Table Global Induced Pluripotent Stem Cells (iPSCs) Revenue Forecast by Application (2019-2024)
Figure Global Induced Pluripotent Stem Cells (iPSCs) Market Share Forecast by Application (2019-2024)
Figure Global Academic Research Revenue Growth Rate (2014-2019)
Figure Global Drug Development and Discovery Revenue Growth Rate (2014-2019)
Figure Global Toxicity Screening Revenue Growth Rate (2014-2019)
Figure Global Regenerative Medicine Revenue Growth Rate (2014-2019)
Figure Global Induced Pluripotent Stem Cells (iPSCs) Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Induced Pluripotent Stem Cells (iPSCs) Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Induced Pluripotent Stem Cells (iPSCs) Revenue Market Forecast (2019-2024)
Figure Europe Induced Pluripotent Stem Cells (iPSCs) Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Revenue Market Forecast (2019-2024)
Figure South America Induced Pluripotent Stem Cells (iPSCs) Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Induced Pluripotent Stem Cells (iPSCs) Revenue Market Forecast (2019-2024)
ヒト胚性幹細胞（HESC）市場：世界及び中国市場分析・予測（～2024年） Human Embryonic Stem Cells (HESC) Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Human Embryonic Stem Cells (HESC) industry with a focus on the Chinese market. The report provides key statistics on the market status of the Hu…- 幹細胞市場：世界及び中国市場分析・予測（～2024年） Stem Cells Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Stem Cells industry with a focus on the Chinese market. The report provides key statistics on the market status of the Stem Cells manufacturers and is a valuable sourc…
- 胎児幹細胞市場：世界及び中国市場分析・予測（～2024年） Fetal Stem Cells Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Fetal Stem Cells industry with a focus on the Chinese market. The report provides key statistics on the market status of the Fetal Stem Cells manufacturers and i…
- ヒト胚性幹細胞市場：世界及び中国市場分析・予測（～2024年） Human Embryonic Stem Cell Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Human Embryonic Stem Cell industry with a focus on the Chinese market. The report provides key statistics on the market status of the Human Embryonic St…
- 世界の化学療法による骨髄抑制治療市場予測（～2024年）：企業別、地域別、種類・用途別 Scope of the Report: The global Chemotherapy-Induced Myelosuppression Treatment market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years…